Opko Health OPK
NASDAQ OPK
$1.63 +0.03 (+1.87%)
At close: Oct 22, 2026 · 4:00 PM EDT

Opko Health (OPK) Non Operating Interest Expenses (2011 - 2026)

Updated

Opko Health (OPK) recorded Non Operating Interest Expenses of $11.38 million in Q2 2026, down 83.8% from $70.33 million a year earlier but up 4.0% from the prior quarter.

Analysis

Opko Health (OPK) Non Operating Interest Expenses (2011 - 2026) Analysis & Trends

On a TTM basis, Opko Health's Non Operating Interest Expenses came in at $44.99 million as of Jun 30, 2026, down 61.7% year-over-year; for FY2025, it came in at $108.46 million, up 128.5% from FY2024.

  • Annual Non Operating Interest Expenses has increased for three straight years, with a five-year compound annual growth rate of 37.7% (FY2020 to FY2025).
  • Across earlier years, Non Operating Interest Expenses came in at $47.47 million in FY2024 (+251.4%), $13.51 million in FY2023 (+12.0%), $12.06 million in FY2022 (-36.1%) and $18.88 million in FY2021 (-13.9%).
  • Quarterly Non Operating Interest Expenses has ranged from $2.66 million in Q1 2022 to $70.33 million in Q2 2025 over the past five years.
  • On a year-over-year basis, Non Operating Interest Expenses has declined for four consecutive quarters, with growth averaging 177.3% over the last eight quarters.
  • Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 759.7% in Q2 2025, against a decline of 83.8% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $10.94 million (Q1 2026), $11.31 million (Q4 2025) and $11.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 247.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Opko Health 1.22 Bn -210.40 Mn 80.02 Mn 11.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.38 Mn
Mar 31, 2026 10.94 Mn
Dec 31, 2025 11.31 Mn
Sep 30, 2025 11.36 Mn
Jun 30, 2025 70.33 Mn
Mar 31, 2025 15.47 Mn
Dec 31, 2024 14.24 Mn
Sep 30, 2024 17.36 Mn
Jun 30, 2024 8.18 Mn
Mar 31, 2024 7.69 Mn
Dec 31, 2023 3.45 Mn
Sep 30, 2023 3.38 Mn
Jun 30, 2023 3.28 Mn
Mar 31, 2023 3.39 Mn
Dec 31, 2022 3.30 Mn
Sep 30, 2022 3.02 Mn
Jun 30, 2022 3.08 Mn
Mar 31, 2022 2.66 Mn
Dec 31, 2021 4.31 Mn
Sep 30, 2021 4.29 Mn
API Access

Opko Health Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=OPK&period=max&api_key=YOUR_API_KEY